CYTOMED THERAPEUTICS stock price
NASDAQ:GDTC · Nasdaq · Healthcare · sector #16$0.9190+5.45%Oct 21 close
Loading chart…
CYTOMED THERAPEUTICS's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is GDTC.
CYTOMED THERAPEUTICS last closed at $0.9190 (+5.45%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -2.1×. Its overall grade ranks 686 of 727 stocks in Healthcare.
About this company
CYTOMED THERAPEUTICS last closed at $0.9190 (+5.45%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 686/727
Valuation grade C+
Related stocks
- NovartisCompetitor
- Bristol Myers SquibbCompetitor
- Gilead SciencesCompetitor
About CYTOMED THERAPEUTICS
- What technical signals does CYTOMED THERAPEUTICS (GDTC) have?
- CYTOMED THERAPEUTICS current technical signals: no active technical signal.
- Is CYTOMED THERAPEUTICS a cup-and-handle pattern?
- No. CYTOMED THERAPEUTICS has no valid Cup signal right now.
- What published figures are available for CYTOMED THERAPEUTICS?
- Trailing 12 months PER: -2.1×. Latest quarter PBR: 2.02×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about CYTOMED THERAPEUTICS, or open the plan table on the main site.
Ask Q about CYTOMED THERAPEUTICS.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy